The epidemiology and the pathogenesis of inflammatory bowel disease

European Journal of Radiology

Volumn 35, Issue 3, 2000, Pages 154-167

  Karlinger, Kinga ^a   Györke, Tamás ^a   Makö, Erno ^a   Mester, Ádám ^a   Tarján, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bacterial; Environmental; Epidemiology; Ethnic; Extra intestinal; Genetic; IBD; Immunological; Pathogenesis; Racial; V iral

Indexed keywords

BACTERIA; BEHAVIORAL RESEARCH; DISEASES; ENVIRONMENTAL ENGINEERING; GENETIC ENGINEERING; IMMUNOLOGY; SOCIAL ASPECTS; VIRUSES;

AUTO IMMUNE INFECTION; CROHN DISEASE; ETIOLOGY; INFLAMMATORY BOWEL DISEASE; PATHOGENESIS; ULCEROUS COLITIS;

EPIDEMIOLOGY;

AUTOIMMUNITY; BACTERIAL INFECTION; ENTERITIS; ENVIRONMENTAL FACTOR; ETHNIC GROUP; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HISTOCOMPATIBILITY; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; VIRUS INFECTION;

EID: 0342844290     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(00)00238-2     Document Type: Article

References (69)

1. Lakatos L. A gyulladásos bélbetegségek epidemiológiája. In: Újszászy L. editor. IBD. Válogatott fejezetek a gyulladásos vastagbélbetegségekröl. Budapest: Medicom 1997. p. 19-26.
2. Shivananda S, Lennard-Jones J, Logan R, EC-IBD Study Group. Incidence of inflammatory disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD), Gut 1996;39:690-697.
3. Loftus E.V. Jr., Silverstein M.D., Sandborn W.J., Tremaine W.J., Harmsen W.S., Zinsmeister A.R. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence and survival. Gastroenterology. 114:1998;1161-1168.
4. Sonnenberg A., McCarty D.J., Jacobsen S.J. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 100:1991;143-149.
5. Nanji A.A., Denardi F.G. Primary adult lactose intolerance protects against development of inflammatory bowel disease. Med. Hypotheses. 19:1986;1-6.
6. Rioux M., Gagnon J. Imaging modalities in the puzzling world of inflammatory bowel disease. Abdom. Imaging. 22:1997;173-174.
7. Hillert J., Kall T., Vrethem M., Fredrikson S., Ohlson M., Olerup O. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. J. Neuroimmunol. 50:1994;95-100.
8. Levine J.B., Lukawski-Turbish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol. Clin. N. Am. 24:1995;633-646.
9. Niv Y., Abiksis G., Fraser G.M. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am. J. Gastroenterol. 94:1999;2961-2965.
10. Odes H.S., Fraser D., Krawiec J. Inflammatory bowel disease in migrant and native Jewish populations in Southern Israel. Scand. J. Gastroenterol. 24(170):1989;36-38.
11. Nagy Gy. A gyulladásos bélbetegségek epidemiológiája Magyarországon. In: Újszászy L. editor. IBD. Válogatott fejezetek a gyulladásos vastagbélbetegségekröl. Budapest: Medicom 1997. p. 27-35.
12. Calkins B.M., Mendeloff A.I. Epidemiology of inflammatory bowel disease. Epidemiol. Rev. 8:1986;60-91.
13. Varró V. A bélrendszer vérellátásának zavarai. Orvosképzés. 57:1982;403-418.
14. Russel M.G., Stockbrugger R.W. Epidemiology of inflammatory bowel disease, an update. Scand. J. Gastroenterol. 31:1996;417-427.
15. Mishkin S. Dairy sensitivity, lactose malabsorbtion and elimination diets in inflammatory bowel disease. Am. J. Clin. Nutr. 65:1997;564-567.
16. Szilágyi A. Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: rationale of dietary manipulation with emphasis on disaccharides. Can. J. Gastroenterol. 12:1998;133-146.
17. Harper P.H., Lee E.C.G., Kettlewell M.G.W., Bennett M.K., Jewell D.P. Role of the faecal stream in the maintenance of Crohn's colitis. Gut. 26:1985;279-284.
18. Whorwell P.J., Holdstock G., Whorwell G.M., Wright R. Bottle feeding, early gastroenteritis and inflammation bowel disease. Br. Med. J. 1:1979;382.
19. Koletzko S., Sherman P., Corey M., Griffiths A., Smith C. Role of infant feeding practices in development of Crohn's disease in childhood. Br. Med. J. 298:1989;1617-1618.
20. Corrao G., Tragnone A., Caprilli R., Trallori G., Papi C., Andredi A., Di-Paolo M., Riegler G., Rigo G.P., Feran O., Mansi C., Ingrosso M., Valpiani D. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case control study. Cooperative investigators of the Italian group for the study of the colon and rectum (GISC). Int. J. Epidemiol. 27:1998;397-404.
21. Lindberg E., Tysk C., Andersson K., Jarnerot G. Smoking and inflammatory bowel disease. A case control study. Gut. 29:1988;352-357.
22. Lashner B.A., Kane S.V., Hanauer S.B. Lack of association between oral contraceptive use and Crohn's disease, a community based matched case-control study. Gastroenterology. 97:1989;1442-1447.
23. Orchard T., Jewell P.D. Review article: pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilaties in clinical findings. Aliment. Pharmacol. Ther. 11:1997;10-16.
24. McConnell R.B., Shaw J.M., Whibley E.J., McConnell T.H. Inflammatory bowel disease: a review of previous family data. Front. Gastrointest. Res. 11:1986;1-11.
25. Hollander D., Vadheim C.M., Brettholz E., Petersen G.M., Delahunty T.J., Rotter J.I. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann. Intern. Med. 105:1986;883-885.
26. May G.R., Sutherland L.R., Meddings J.B. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology. 104:1993;1627-1632.
27. Burke D.A., Axon A.T.R. Ulcerative colitis and Escherichia coli with adhesive properties. J. Clin. Pathol. 40:1987;782-786.
28. Montgomery S.M., Morris D.L., Pounder R.E., Wakefield A.J. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology. 116:1999;796-803.
29. Feeney M., Ciegg A., Winwood P., Snook J. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet. 13(350):1997;764-766.
30. Pardy D.S., Tremaine W.J., Sandborn W.J., Loftus E.V. Jr., Poland G.A., Meton L.J. Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease. Inflamm. Bowel Dis. 5:1999;104-106.
31. Burnham W.R. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet. 2:1978;693-696.
32. Rowbotham D.S., Houdle P.D., Trojdosiewicz L.K. Periferal cell-mediated immune response to mycobacterial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 102:1995;456-461.
33. Cohary O., Harth G., Horowitz M? Eggena M., Landers C., Sutton C., Targan S.R., Braun J. Identification of a novel micobacterial histone H1 homologue (HupB) is an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect. Immun. 67:1999;6510-6517.
34. Greenstein J., Lachman P., Sachar D.B., Springhorn J., Heimann T., Janowitz H.D., Aufses A.H. Jr. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 29:1988;588-592.
35. El Zataari F.A., Naser S.A., Hulten K., Burch C., Graham D.Y. Characterisation of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr. Microbiol. 39:1999;115-119.
36. Kovács Á. Az IBD klinikai immunológiai háttere. In: Újszászy L, editor. IBD Válogatott fejezetek a gyulladásos vastagbélbetegségekröl, Budapest: Medicom 1997, p. 67-70.
37. Saxon A., Shanahan F., Lander C., Gonz T., Targan S.R. A distinct subset of anti-neutrophil cytoplasmic antibodies in associated with inflammatory bowel disease. J. Allergy Clin. Immunol. 86:1990;202-210.
38. Mizoguchi A., Mizoguchi E., Chiba C., Bhan A.K. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J. Exp. Med. 184:1996;707-715.
39. Mizoguchi A., Mizoguchi E., Tonegawa S., Bhan A.K. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR - a mutant mice with inflammatory bowel disease. Int. Immunol. 8:1996;1387-1394.
40. Targan S.R. The search for pathogenic antigens in ulcerative colitis. Gastroenterology. 114:1998;1099-1100.
41. Arányi L. A kórbonctan elemei. Magyar Királyi Egyetemi Nyomda. Buda, 1864.
42. Talal A.H., Drossman D.A. Psychosocial factors in inflammatory bowel disease. Gastroenterol. Clin. N. Am. 24:1995;699-716.
43. Heikius B., Niemela S., Lehtola J., Karttunen T., Lahde S. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 32:1997;153-161.
44. Eckhardt R. Leberveranderungen bei Morbus Crohn und Colitis ulcerosa. Dtsch. Med. Wschr. 103:1978;1983-1985.
45. Harmatz A. Hepatobiliary manifestations of inflammatory bowel disease. Med. Clin. N. Am. 78:1994;1387-1398.
46. Lee Y.-M., Kaplan M.M. Primary sclerosing cholangitis. N. Engl. J. Med. 332:1995;924-933.
47. Manns, MP, Kryger M. Immunogenetics of chronic liver diseases, Gastroenterology 1994;106:1976-1997.
48. Chapman T.W.G. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin. Liver Dis. 11:1991;1-4.
49. Raj D., Lichtenstein D.R. Hepatobiliary manifestations of inflammatory bowel disease. Gastroenterol. Clin. N. Am. 28:1999;491-513.
50. Balan V., LaRusso N.F. Hepatobiliary disease in inflammatory bowl disease. Gastroenterol. Clin. N. Am. 24:1995;647-669.
51. Wiesner R.H. Current concepts in primary sclerosing cholangitis. Mayo Clin. Proc. 69:1994;969-982.
52. Nemesanszky E, Csepregi A. A gyulladasos belbetegsegek hepatologiai vonatkozasai. In: Ujszaszi L. editor. IBD. Valogatott fejezetek a gyulladasos vastagbelbetegsegekrol. Budapest: Medicom 1997:157-165.
53. Katz S., Bank S., Geenberg R.E., Landvai S., Lesser M., Napolitano B. Hyperamylasemia in inflammatory bowel disease. J. Clin. Gastroenterol. 10:1988;627-630.
54. Borkje B., Vetvik K., Odegaard S., Schrumpf E., Larssen T.B., Kolmannskogg F. Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative cholitis. Scand. J. Gastroenterol. 20:1990;539-542.
55. Tromm A, May B. Pancreasbeteiligung beim Morbus Crohn. In: Demling L, editor. Extraintestinale Manifestationen des Morbus Crohn. Neu-Isenburg: Lingua Med, 1996. p. 13-19.
56. Siebold F., Weber P., Jenss H., Wiedmann K.H. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut. 32:1992;1192-1197.
57. Burgdorf W. Cutaneous manifestations of Crohn's disease. Am. J. Acad. Dermatol. 5:1981;689-695.
58. Apgar J.T. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin. Dermatol. 10:1991;138-147.
59. Horváth A., Temesvári E. A Crohn syndroma borgyógyászati vonatkozásai. Magyar. Belorv. Arch. 5:1995;325-329.
60. Kypke W. Ophthalmologische Manifestationen bei Morbus Crohn. In: Demling L, editor. Exraintestinale Manifestationen des Morbus Crohn. Neu Isenburg: Lingua Med, 1996, p. 55-60.
61. Habeeb M.A., Rajalingam R., Dhar A., Kumar A., Sharma M.P., Mehra N.K. HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis. Am. J. Gastroenterol. 92:1997;772-776.
62. Hofley P., Roarty J., McGinnity G., Griffits A.M., Marcon M., Kraft S., Sherman P. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J. Pediatr. Gastroenterol. Nutr. 17:1993;397-400.
63. Hammer H. A gyulladásos bélbetegségek szemészeti tünetei. In: Újszászy L, editor. IBD. Válogatott fejezetek a gyulladásos vastagbélbetegségekröl. Budapest: Medicom, 1997, p. 149-150.
64. Nagy Gy. Egyéb extraintestinalis manifesztációk. In: Újszászy L, editor. IBD. Válogatott fejezetek a gyulladásos vastagbélbetegségekröl. Budapest: Medicom, 1997, p. 167-174.
65. Björkengren A.G., Resnick D., Sartorius D.J. Enteropathic arthropathies. Radiol. Clin. N. Am. 25:1987;189-198.
66. Schorr-Lesnick B., Brandt L.J. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am. J. Gastroenterol. 83:1988;216-223.
67. Scott W.W., Fishman E.K., Kushman J.E., Kaskey C.L., O'Brien J.J., Walia G.S., Bayless M. Computed tomography evaluation of sacroiliac joints in Crohn's disease: radiographical/clinical correlation. Skeletal Radiol. 19:1990;207-210.
68. Scarpa R., D'Arienzo A., del Puente A., Panarese A., Girolamo C., Larizza G., Della Valle G., Oriente A., Lubrano E., Oriente P. Reverse correlation between extent of colon involvement and number of affected joints with ulcerative colitis and arthritis. Am. Gastroenterol. 85:1990;331-332.
69. Mielants H., Veys E.M., Goemaere S., Goethals K., Cuvelier C., De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology: a prospective study. J. Rheumatol. 18:1991;1542-1551.